Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genicular Nerve Block in Rheumatoid Arthritis
NCT04361513Phase 4Completed
- Sponsor
- Sohag University
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in rheumatoid arthritis (RA), sponsored by Sohag University. Primary endpoints: Pain changes by Visual Analogue Scale at 12 weeks, Sonographic Large Joint Rheumatoid Arthritis Score at 12 weeks and 1 more. Started Apr 2020; status: completed.
02
Drugs
bupivacaine
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT04361513.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04361513.